While Legend Biotech Corp ADR has overperformed by 1.84%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LEGN rose by 21.21%, with highs and lows ranging from $77.32 to $44.52, whereas the simple moving average fell by -12.41% in the last 200 days.
On March 13, 2024, Raymond James started tracking Legend Biotech Corp ADR (NASDAQ: LEGN) recommending Outperform. A report published by Scotiabank on December 19, 2023, Initiated its previous ‘Sector Perform’ rating for LEGN. Goldman also rated LEGN shares as ‘Buy’, setting a target price of $90.09 on the company’s shares in an initiating report dated November 06, 2023. William Blair Initiated an Mkt Perform rating on May 25, 2023, and assigned a price target of $64. Daiwa Securities initiated its ‘Buy’ rating for LEGN, as published in its report on May 22, 2023. H.C. Wainwright’s report from March 29, 2023 suggests a price prediction of $66 for LEGN shares, giving the stock a ‘Buy’ rating. RBC Capital Mkts also rated the stock as ‘Outperform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Legend Biotech Corp ADR (LEGN)
Further, the quarter-over-quarter increase in sales is 190.43%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Legend Biotech Corp ADR’s future performance, with equity being one of the most critical indicators. Taking into account the quick ratio of the company, currently set at 6.83, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and LEGN is recording an average volume of 976.40K. On a monthly basis, the volatility of the stock is set at 4.99%, whereas on a weekly basis, it is put at 4.74%, with a loss of -5.16% over the past seven days. Furthermore, long-term investors anticipate a median target price of $86.73, showing growth from the present price of $56.93, which can serve as yet another indication of whether LEGN is worth investing in or should be passed over.
How Do You Analyze Legend Biotech Corp ADR Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.98%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 46.96% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
LEGN shares are owned by institutional investors to the tune of 46.96% at present.
